AMYE THOMAS: Open Payments
NPI 1295406494 · WHITESBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 11 payments from 8 companies in 2025. Trend: 2023 $55 · 2024 $158 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| ABBVIE INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: HETLIOZ, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, UZEDY, Kerendia, Auvelity, REXULTI.
Industry payments across KY — which companies pay providers there.
